title: [Advances in the treatment of the dystonias].
abstract: Except in Wilson's disease, few secondary dystonias are susceptible te benefit from an etiological treatment. The somatic distribution of dystonia often determines the therapeutic strategy. Thus, stereotactic surgery may be the treatment of choice for hemidystonia while anticholinergic medication may alleviate generalized dystonia, particularly in childhood. Finally, local infiltrations of botulinum toxin are particularly useful for various forms of local and segmental dystonia. Certain subsyndromes as myoclonic dystonia, levodopa sensitive dystonia and paroxysmal choreoathetosis may benefit from relatively specific treatment strategies.
authors.affiliation: Servicio de Neurología, Hospital General Gregorio Marañón, Madrid.
authors.forename: S
authors.initials: S
authors.lastname: Giménez-Roldán
mesh_terms: D001764:Blepharospasm / Q000188:drug therapy; D001905:Botulinum Toxins / Q000627:therapeutic use*; D004421:Dystonia / Q000188:drug therapy / Q000209:etiology / Q000601:surgery / Q000628:therapy*; D004422:Dystonia Musculorum Deformans / Q000188:drug therapy / Q000601:surgery; D006801:Humans; D007980:Levodopa / Q000627:therapeutic use; D010276:Parasympatholytics / Q000627:therapeutic use*; D013238:Stereotaxic Techniques; D013788:Thalamus / Q000601:surgery*
chemical_list: D010276:Parasympatholytics; D007980:Levodopa; D001905:Botulinum Toxins
vernacular_title: Avances en el tratamiento de las distonías.